Aclarion, Inc. (ACON)
Nasdaq: ACON · Services-Medical Laboratories · Broomfield, CO · filing with the SEC since 2015
Who owns Aclarion, Inc.
As filed with the SECHolders of 5% or more
1
SEG Opportunity Fund, LLC holds 9.98% of Common Stock, $0.00001 par value per share, as its SCHEDULE 13G filed Mar 25, 2026 says.
Directors and officers
9
report now, of 10 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
SEG Opportunity Fund, LLC
SCHEDULE 13G · filed Mar 25, 2026 · Common Stock, $0.00001 par value per share · 0% in Feb 13, 2025
What ACON reports owning in othersstakes of 5% or more, and other ties
Aclarion, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
11purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ness Brent | Chief Executive Officer | 0 | $0 | 0 | 3 | $0 |
| Neal David K | director | 0 | $0 | 0 | 2 | $0 |
| Wesemann William | director | 0 | $0 | 0 | 2 | $0 |
| Gould Gregory A | CFO | 0 | $0 | 0 | 1 | $0 |
| Bond Ryan | Chief Strategy Officer | 0 | $0 | 0 | 1 | $100,000 |
| Sequira Amanda Mae | director | 0 | $0 | 0 | 1 | $0 |
| Breidbart Scott | director | 0 | $0 | 0 | 1 | $0 |